NO995908L - Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav - Google Patents

Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav

Info

Publication number
NO995908L
NO995908L NO995908A NO995908A NO995908L NO 995908 L NO995908 L NO 995908L NO 995908 A NO995908 A NO 995908A NO 995908 A NO995908 A NO 995908A NO 995908 L NO995908 L NO 995908L
Authority
NO
Norway
Prior art keywords
preparation
controlled release
pharmaceutically active
implants
core
Prior art date
Application number
NO995908A
Other languages
English (en)
Other versions
NO995908D0 (no
Inventor
Alexandra Rothen-Weinhold
Robert Gurny
Piero Orsolini
Frederic Heimgartner
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Publication of NO995908L publication Critical patent/NO995908L/no
Publication of NO995908D0 publication Critical patent/NO995908D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
NO995908A 1997-06-04 1999-12-02 Implantater for kontrollert frigivning av farmasöytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav NO995908D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706874 1997-06-04
PCT/EP1998/003270 WO1998055101A1 (fr) 1997-06-04 1998-06-02 Implants pour la liberation controlee de principes pharmaceutiquement actifs et procede pour leur fabrication

Publications (2)

Publication Number Publication Date
NO995908L true NO995908L (no) 1999-12-02
NO995908D0 NO995908D0 (no) 1999-12-02

Family

ID=9507573

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995908A NO995908D0 (no) 1997-06-04 1999-12-02 Implantater for kontrollert frigivning av farmasöytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav

Country Status (10)

Country Link
US (1) US6319512B1 (no)
EP (1) EP1001743B1 (no)
JP (1) JP2002511075A (no)
AT (1) ATE316779T1 (no)
AU (1) AU742372B2 (no)
CA (1) CA2291659A1 (no)
DE (1) DE69833375D1 (no)
IL (1) IL133105A (no)
NO (1) NO995908D0 (no)
WO (1) WO1998055101A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767550B1 (en) * 2000-06-30 2004-07-27 Berkeley Advanced Biomaterials, Inc. Hydroxyapatite based drug delivery implant for cancer treatment
AU2001296770A1 (en) * 2000-10-06 2002-04-15 Durect Corporation Devices and methods for management of inflammation
US7666445B2 (en) * 2000-10-20 2010-02-23 The Trustees Of The University Of Pennsylvania Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
JP2004535431A (ja) 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
RU2302883C2 (ru) * 2001-08-31 2007-07-20 Шеринг Ой Система доставки лекарств
DE10237572A1 (de) * 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
SE0202619D0 (sv) * 2002-09-05 2002-09-05 Fredrik Nederberg New Polymers and Applications
US8329203B2 (en) * 2004-01-12 2012-12-11 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8221778B2 (en) * 2005-01-12 2012-07-17 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
CA2553254C (en) * 2004-01-12 2013-12-17 The Trustees Of The University Of Pennsylvania Long-term delivery formulations and methods of use thereof
WO2007011955A2 (en) * 2005-07-18 2007-01-25 The Trustees Of The University Of Pennsylvania Drug-containing implants and methods of use thereof
US8119154B2 (en) * 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107715A1 (en) * 2004-05-11 2005-11-17 Debio Recherche Pharmaceutique S.A. Implantable composition
EP1781264B1 (en) 2004-08-04 2013-07-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
RU2464972C2 (ru) * 2005-12-22 2012-10-27 Новартис Аг Композиции с замедленным высвобождением, включающие октреотид и два или более сополимера полилактида и гликолида
CA2648479C (en) * 2006-04-06 2014-10-28 Nupathe Inc. Implants for the treatment of dopamine associated states
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
ITMI20061538A1 (it) * 2006-08-02 2008-02-03 Mediolanum Pharmaceuticals Ltd Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
EP2222281B1 (en) 2007-12-20 2018-12-05 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
EP2391396B1 (en) * 2009-02-02 2014-04-09 Medtronic, Inc Antimicrobial accessory for an implantable medical device
EP2246063A1 (en) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. Sustained release formulations comprising GnRH analogues
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
EP2464389A2 (en) 2009-08-06 2012-06-20 Koninklijke Philips Electronics N.V. Oncology therapies employing radioactive seeds
IN2012DN02656A (no) * 2009-09-17 2015-09-11 Evonik Degussa Corp
US8911427B2 (en) 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
JPH0778017B2 (ja) * 1985-12-28 1995-08-23 住友製薬株式会社 パルス的かつ持続放出性製剤
US4894231A (en) 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
EP0514406B1 (en) * 1990-01-30 1994-03-02 Akzo Nobel N.V. Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
CA2141459A1 (en) * 1992-07-31 1994-02-17 Richard Yu Controlled release implants
JP3720386B2 (ja) 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
ATE284202T1 (de) * 1996-02-02 2004-12-15 Alza Corp Implantierbares system mit verzögerter wirkstofffreisetzung

Also Published As

Publication number Publication date
US6319512B1 (en) 2001-11-20
EP1001743A1 (fr) 2000-05-24
WO1998055101A1 (fr) 1998-12-10
AU742372B2 (en) 2002-01-03
DE69833375D1 (de) 2006-04-13
EP1001743B1 (fr) 2006-02-01
ATE316779T1 (de) 2006-02-15
IL133105A (en) 2004-09-27
CA2291659A1 (fr) 1998-12-10
IL133105A0 (en) 2001-03-19
AU8109398A (en) 1998-12-21
NO995908D0 (no) 1999-12-02
JP2002511075A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
NO995908L (no) Implantater for kontrollert frigivning av farmasoeytisk aktive bestanddeler samt fremgangsmåte for fremstilling derav
PT90153A (pt) Processo para a preparacao de composicoes farmaceuticas de libertacao controlada
SE9803871D0 (sv) Therapeutic method and formulation
CA2158638A1 (en) A Composition and a Method for Tissue Augmentation
NO964939D0 (no) Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte
NO303425B1 (no) FremgangsmÕte for behandling av et kirurgisk metallimplantat
HUT50624A (en) Process for producing pharmaceuical compositions with controlled release of active ingredient
AU6798890A (en) Controlled release pharmaceutical preparation and method for producing the same
AU1025199A (en) Coated medical implants, method for producing them, and use of the same for preventing restenosis
EP0923955A3 (en) Manufacturing method of artificial organ, hollow fiber membrane, and dialyzer of hollow fiber membrane type
ITBO920452A0 (it) "metodo per la realizzazione di protesi da implantologia e dispositivoper l'attuazione di tale metodo".
NO995843D0 (no) Farmasöytisk preparat omfattende vWF-propeptid
PL312491A1 (en) Novel benzoguanidine derivatives, method of obtaining them, their application for producing pharmaceutical agents, method of treating arrhytmia and pharmaceutical agent as such
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
FR2845289B1 (fr) Spheroides, procede de preparation et compositions pharmaceutiques.
HUP9900304A3 (en) Composition for ph dependent controlled release of active ingredients and methods for producing it
AP9801416A0 (en) Method Of treating a plant disease.
GEP19991819B (en) Method for Production of Therapeutic Form of Carbamazepin with Retarded Active Substance Release
GR3035533T3 (en) Active substance controlled release devices and process for producing the same
DK0830106T3 (da) Vævsladesystem til implanterbare biologiske indretninger
PL324181A1 (en) Substituted hydrasine phenylsulphonyl ireas, method of obtaining them and their application as herbicides and plant growth controlling agents
PL317174A1 (en) Method of producing an active layer on surfaces of medical implants
WO2001095916A3 (de) Anticholestatisches arzneimittel
PL314832A1 (en) Application of balhymycin as an agent increasing animal production, animal production increasing agent and method of obtaining such agent
HUT76434A (en) Equippment and method for making high precise film of silicone gum olygomer with or without active ingredient

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application